Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine review

Scott N. Compton, Christopher J Kratochvil, John S. March

Research output: Contribution to journalReview article

5 Citations (Scopus)

Abstract

These studies generally support the use of the SSRIs fluvoxamine, sertraline, and fluoxetine in the acute treatment of pediatric non-OCD anxiety disorders. Two large multicenter studies suggest a favorable outcome for paroxetine in the treatment of pediatric social anxiety disorder. Mixed results currently exist for the use of extended-release venlafaxine in the treatment of pediatric generalized anxiety disorder. In both of these latter studies, concerns with safety were present.

Original languageEnglish (US)
Pages (from-to)504-517
Number of pages14
JournalPsychiatric Annals
Volume37
Issue number7
StatePublished - Jul 1 2007

Fingerprint

Evidence-Based Medicine
Anxiety Disorders
Pediatrics
Drug Therapy
Fluvoxamine
Sertraline
Paroxetine
Fluoxetine
Multicenter Studies
Therapeutics
Safety

ASJC Scopus subject areas

  • Psychiatry and Mental health

Cite this

Pharmacotherapy for anxiety disorders in children and adolescents : An evidence-based medicine review. / Compton, Scott N.; Kratochvil, Christopher J; March, John S.

In: Psychiatric Annals, Vol. 37, No. 7, 01.07.2007, p. 504-517.

Research output: Contribution to journalReview article

@article{8a537a482180427f82ad803f6c54abdb,
title = "Pharmacotherapy for anxiety disorders in children and adolescents: An evidence-based medicine review",
abstract = "These studies generally support the use of the SSRIs fluvoxamine, sertraline, and fluoxetine in the acute treatment of pediatric non-OCD anxiety disorders. Two large multicenter studies suggest a favorable outcome for paroxetine in the treatment of pediatric social anxiety disorder. Mixed results currently exist for the use of extended-release venlafaxine in the treatment of pediatric generalized anxiety disorder. In both of these latter studies, concerns with safety were present.",
author = "Compton, {Scott N.} and Kratochvil, {Christopher J} and March, {John S.}",
year = "2007",
month = "7",
day = "1",
language = "English (US)",
volume = "37",
pages = "504--517",
journal = "Psychiatric Annals",
issn = "0048-5713",
publisher = "Slack Incorporated",
number = "7",

}

TY - JOUR

T1 - Pharmacotherapy for anxiety disorders in children and adolescents

T2 - An evidence-based medicine review

AU - Compton, Scott N.

AU - Kratochvil, Christopher J

AU - March, John S.

PY - 2007/7/1

Y1 - 2007/7/1

N2 - These studies generally support the use of the SSRIs fluvoxamine, sertraline, and fluoxetine in the acute treatment of pediatric non-OCD anxiety disorders. Two large multicenter studies suggest a favorable outcome for paroxetine in the treatment of pediatric social anxiety disorder. Mixed results currently exist for the use of extended-release venlafaxine in the treatment of pediatric generalized anxiety disorder. In both of these latter studies, concerns with safety were present.

AB - These studies generally support the use of the SSRIs fluvoxamine, sertraline, and fluoxetine in the acute treatment of pediatric non-OCD anxiety disorders. Two large multicenter studies suggest a favorable outcome for paroxetine in the treatment of pediatric social anxiety disorder. Mixed results currently exist for the use of extended-release venlafaxine in the treatment of pediatric generalized anxiety disorder. In both of these latter studies, concerns with safety were present.

UR - http://www.scopus.com/inward/record.url?scp=34548029178&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34548029178&partnerID=8YFLogxK

M3 - Review article

AN - SCOPUS:34548029178

VL - 37

SP - 504

EP - 517

JO - Psychiatric Annals

JF - Psychiatric Annals

SN - 0048-5713

IS - 7

ER -